Ryman Healthcare Limited (NZX: RYM) Half Year Report

The first half unaudited underlying profit dropped by 14.2% to $88.4 million, due to restrictions on sales and construction activity caused by the pandemic.

Unaudited reported (IFRS) profit, which includes unrealised fair value gains on investment property, increased 12.8% to $212.4 million in the six months to 30 September.

Shareholders will receive an interim dividend of 8.8 cents per share in line with 50% of underlying profit.

The record date for entitlements is 11 December, and the dividend will be paid on 18 December 2020.

Ryman has a record number of new villages in the pipeline.

While there is likely to be some ongoing uncertainty due to the pandemic, there is clearly a lot of pent-up demand in the housing market. Ryman is anticipating cash collections of at least $275 million in the second half from new sales. With 12 villages under construction and more on the way, Ryman has a strong platform for growth.

See the link below for more details:

Ryman Half Year Report 2020

Source: Ryman Healthcare Limited

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

Tourism Holdings Limited (NZX: THL) Market Update
Delegat Group Limited (NZX: DGL) 2021 Harvest Announcement
Kiwi Property Group Limited (NZX: KPG) Gives Green Light to New Sylvia Park Office Building
Just Life Group Limited (NZX: JLG) Invests in Domestic Rainwater Tank Business
NZME Limited (NZX: NZM) NZ Markets Disciplinary Tribunal Censures
Rua Bioscience Limited (NZX: RUA) Announces CCO with Global Pharma Experience
Cannasouth Limited (NZX: CBD) Supply Activity Added to Cannasouth Commercial Licence
Skellerup Holdings Limited (NZX: SKL) Upgrades FY21 Earnings Guidance
Napier Port Holdings Limited (NZX: NPH) 2021 Earnings Guidance Update
Comvita Limited (NZX: CVT) Full Year Guidance Update